B. Oyan Et Al. , "The change in the status of MGMT methylation and IDH mutation in initial and recurrent glial tumors and its relation with prognosis.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , vol.33, Illinois, United States Of America, 2015
Oyan, B. Et Al. 2015. The change in the status of MGMT methylation and IDH mutation in initial and recurrent glial tumors and its relation with prognosis.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , (Illinois, United States Of America).
Oyan, B., Ozturk, M. A., Ozkan, F., Eren, O. O., & Sonmez, Ö., (2015). The change in the status of MGMT methylation and IDH mutation in initial and recurrent glial tumors and its relation with prognosis. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America
Oyan, BAŞAK Et Al. "The change in the status of MGMT methylation and IDH mutation in initial and recurrent glial tumors and its relation with prognosis.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 2015
Oyan, BAŞAK O. Et Al. "The change in the status of MGMT methylation and IDH mutation in initial and recurrent glial tumors and its relation with prognosis.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America, 2015
Oyan, B. Et Al. (2015) . "The change in the status of MGMT methylation and IDH mutation in initial and recurrent glial tumors and its relation with prognosis.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={BAŞAK OYAN ULUÇ Et Al. }, title={The change in the status of MGMT methylation and IDH mutation in initial and recurrent glial tumors and its relation with prognosis.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer}, city={Illinois}, country={United States Of America}, year={2015}}